Cytomegalovirus Infection in Immunocompromised Patients
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection in Immunocompromised Patients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients [Phase 2]
Phase 2 trial evaluating safety and efficacy of a new antiviral to prevent CMV reactivation in bone marrow transplant patients; study comple…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001) [Phase 3]
Phase 3 trial evaluating letermovir versus placebo for preventing clinically significant CMV infection in CMV-seropositive adult allogeneic …